PARP Inhibitor Upregulates PD-L1 Expression and Provides a New Combination Therapy in Pancreatic Cancer

Yali Wang(Henan Medical University), Yanmei Zou(Online Technologies (United States))
Frontiers in Immunology
December 17, 2021
Cited by 38


Related Papers